The best of both worlds: Can something tangible come from the merging of two different microworlds? An application of lab-on-a-chip technology in the nuclear medical field for the synthesis of positron emission tomography radiopharmaceuticals demonstrates this possibility.
No takes yet. Share an insight, caveat, or question.
Hélène Audrain (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: